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Ferritin is a sub-family of iron binding proteins that form multi-subunit nanotype iron storage structures
and prevent oxidative stress induced apoptosis. Here we describe the identiﬁcation and characterization
of human ferritin, heavy polypeptide 1 (FTH1) as a suppressor of the pro-apoptotic murine Bax sequence
in yeast. In addition we demonstrate that FTH1 is a general pro-survival sequence since it also prevents
the cell death inducing effects of copper when heterologously expressed in yeast. Although ferritins are
phylogenetically widely distributed and are present in most species of Bacteria, Archaea and Eukarya,
ferritin is conspicuously absent in most fungal species including Saccharomyces cerevisiae. An in silico
analysis of the yeast proteome lead to the identiﬁcation of the 161 residue RGI1 (YER067W) encoded
protein as a candidate for being a yeast ferritin. In addition to sharing 20% sequence identity with the 183
residue FTH1, RGI1 also has similar pro-survival properties as ferritin when overexpressed in yeast.
Analysis of recombinant protein by SDS-PAGE and by electron microscopy revealed the expected for-
mation of higher-order structures for FTH1 that was not observed with Rgi1p. Further analysis revealed
that cells overexpressing RGI1 do not show increased resistance to iron toxicity and do not have en-
hanced capacity to store iron. In contrast, cells lacking RGI1 were found to be hypersensitive to the toxic
effects of iron. Overall, our results suggest that Rgi1p is a novel pro-survival protein whose function is not
related to ferritin but nevertheless it may have a role in regulating yeast sensitivity to iron stress.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Iron is an essential co-factor for numerous proteins that are
involved in a large variety of different biological functions that
range from oxygen and electron transport to DNA synthesis and
maintenance [1]. The ferritin-like super-family of proteins is one of
the largest groups of iron binding proteins [2,3]. Members of these
12 sub-families contain a structurally and evolutionary related
iron binding domain that is present in a number of different
functional proteins. The ferritin sub-family consists of three dis-
tinct members including the ferritins, the bacterioferritins and the
DPS (DNA-binding protein from starved cells) [2]. These proteinsInc. This is an open access article u
e yeast RGI1.
Chemical Engineering, Royal
s, Kingston, Ontario, Canada
Greenwood).
ually to this work.are capable of binding iron and they are also capable of acting as
storage molecules. These proteins carry out this function by
forming multi-subunit nano-cage like structures that can store as
much as 4000 iron atoms in the large multi-subunit structure
formed by ferritin [4]. In addition, the ferritin proteins can protect
cells from the toxic effects of iron as well as other free radical
producing stresses such as hydrogen peroxide (H2O2) [2,4–6].
The unique chemistry of metals such as iron, which has the
ability to switch oxidative states (Fe3þþė2Fe2þ – ė), makes
these atoms indispensable for biological systems for such func-
tions as a carrier of electrons [1,7]. There are, however, numerous
problems associated with the use of iron including the fact that
although iron is very abundant, most forms are insoluble and are
thus not easily accessible biologically [7]. Of further importance is
the toxicity associated with iron in vivo. In a series of different
reactions, including the Fenton's reactions, both Fe3þ and Fe2þ
can react with other cellular molecules including H2O2 to produce
destructive free radicals including OH [1,4,7]. Cells have devel-
oped a large repertoire of mechanisms to deal with free radicalsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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regulatory mechanisms have evolved to allow cells to grow and
survive in environments with either excess or limiting levels of
iron [9,10]. One is to coordinately increase and decrease the ex-
pression of genes that code for proteins such as iron transporters
that alter iron uptake [11]. Another mechanism of importance
involves using ferritin cages to safely store excess iron and serve as
a reservoir in times of iron limitation [4,12]. Although the ferritin
sub-family may be one of the most well studied iron binding
proteins many unanswered questions remain including under-
standing the mechanism responsible for the protective effects of
ferritins against ROS [2,3,13–15]. The yeast Saccharomyces cerevi-
siae is an excellent model to study iron metabolism given that
there are a great number of similarities between yeast and humans
[9]. One notable difference is the absence of the ferritin iron sto-
rage proteins in many fungi including yeast [15]. Hence iron sto-
rage is thought to involve the vacuole in yeast while its mamma-
lian counterpart, the lysosome, appears to play a less prominent
role than ferritin in iron storage [10,15].
Here we report that human ferritin, heavy polypeptide 1
(FTH1) was identiﬁed in a previously described screen for se-
quences that prevent cell death in yeast in response to the het-
erologous expression of the murine apoptogenic Bax [16]. In ad-
dition, we report that we identiﬁed a 20% sequence similarity
between the protein encoded by the functionally uncharacterized
RGI1 (YER067W) gene in yeast and FTH1. Other similarities and
links between ferritin and RGI1 include the previously reported
observation that RGI1 expression is responsive to iron and to the
heterologous expression of human ferritin [17,18]. Given that yeast
has no reported ferritin and the importance of ferritin for iron
metabolism, we carried out a detailed functional analysis of RGI1
to examine its potential role in iron metabolism as well as its
ability to function as a negative regulator of Programmed Cell
Death (PCD).Fig. 1. Identiﬁcation of the yeast RGI1 gene as a Bax suppressor. (A) Spot assay of cells e
yeast cells harbouring Bax or Bax and human H-ferritin (hFerritin) were serially diluted a
inducing galactose media. (B) The 183 amino acid sequence of human (h) H-ferritin is s
The sequences were aligned using the Blast program and manually adjusted to maximize
residue and gaps indicate no residue (-). Regions of α-helices deduced by an algorithm us
bold and underlined. Inverted triangles (▼) denote residues that are important for the fe
cells expressing Bax alone or Bax with RGI1. In (A) and (C), 14-3-3 is a positive control2. Results
2.1. Both human ferritin, heavy polypeptide 1 (FTH1) and yeast RGI1
are Bax suppressors in yeast
In a previous screen of a human cardiac cDNA expression li-
brary for suppressors of the pro-apoptotic Bax, we isolated an 874
nt cDNA with a 3′ poly A tail that has a predicted ORF between nt
138–687. Analysis of the sequence of the predicted183 aa residue
protein revealed that it represents human ferritin, heavy poly-
peptide 1 (FTH1) (GenBank BC104643). To conﬁrm the results of
the screen, the FTH1 cDNA was re-transformed into naïve yeast
cells with the Bax expressing cDNA. The transformants were
grown in liquid glucose media, serially diluted and aliquots were
spotted onto nutrient agar media with glucose or galactose. The
Bax and FTH1 sequences are expressed under the control of the
yeast GAL1 promoter and are thus induced in media that contains
galactose. With glucose, all strains grew equally well but cells
harbouring Bax alone showed, as expected, a signiﬁcant inhibition
of growth when plated on media containing galactose (Fig. 1A). In
contrast, cells that co-express FTH1 or human 14-3-3β/α, a pre-
viously characterized Bax suppressor [19], show signiﬁcant growth
on galactose. This conﬁrms that FTH1 is a Bax suppressor and gi-
ven that ferritin is a known pro-survival protein, FTH1 thus ap-
pears to be a functional protein in yeast [18,20].
The widespread distribution of ferritins in all species except
yeast suggests that ferritins were lost or systematically eliminated
from fungal genomes [3,15]. Alternatively it is possible that yeast
have ferritins but that their sequences have diverged to such an
extent that they are not identiﬁable by routine Blast searches. The
latter is supported by studies reporting a ferritin-like iron binding
protein is present in the extracts of S. cerevisiae [21]. Although
many yeast proteins retain high sequence identity with their hu-
man counterparts many others show more limited identity in the
20% range [22–24]. In our search of the yeast proteome in the
Saccharomyces Genome Database (SGD; http://www.yeastgenome.
org/), we identiﬁed the 161 residue protein encoded by YER067Wxpressing Bax alone and Bax with human ferritin. Fresh cultures of glucose grown
nd aliquots were spotted on nutrient agar plates with glucose or the GAL1 promoter
hown aligned to the deduced 161 residue amino acid sequence of RGI1 (YER067W).
identity. A colon (:) indicates a conserved residue, a point (.) represents a conserved
ing the method of Chou and Fasman (http://web.expasy.org/protscale/) are shown in
rroxidase activity of H-ferritin. (C) The spot assay was used to assess the growth of
that refers to the previously characterised Bax suppressor human 14-3-3β/α.
Fig. 2. Yeast RGI1 and human ferritin protect from copper mediated cell death. (A) The spot assay was used to assess the ability of wild type cells expressing ferritin and RGI1
to grow when challenged with copper. (B) The viability of ferritin and RGI1 expressing strains untreated () or treated with (þ) 1.4 mM copper (CuSO4) was determined by
examining cells stained with trypan blue. Viability is shown as the mean percentage (%) of the cells that survived after treatment in triplicate experiments that were repeated
at least 3 times. *, denotes signiﬁcant differences with copper treated control cells (Vector) (student t test, po0.001). (C) A spot assay using the isogenic strain lacking a
functional metacaspase encoding gene (MCA1Δ) expressing human ferritin or yeast RGI1. (D) To monitor ROS levels, RGI1 expressing cells were treated without or with
1.8 mM copper (þCuSO4) for 2 h. The cultures were then incubated for an additional 2 h with 0.1 mg/ml of DCFH-DA. The cells were examined by light (DIC) and ﬂuorescent
light (DCFH-DA) microscopy and representative photographs are shown.
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FTH1 encoded protein (Fig. 1B). YER067W is a poorly characterized
gene of unknown function that has been called Respiratory
Growth Induced (RGI1) [17,18]. Crystallographic analysis of a
N-terminally truncated Rgi1p11-161 protein reveals that the
N-terminal region of Rgi1p is made up predominantly of α-helix
while the C-terminal half consists of mainly of β-sheets [17,18].
This differs from the conserved ferritin structure that consists
mainly of a series of ﬁve α-helixes throughout its entire structure
[3,4]. Thus although there are some similarities, the structural data
nonetheless suggests that Rgip is unlikely to be a ferritin. Never-
theless because RGI1 expression is regulated by iron and the fact
that atypical ferritins have been identiﬁed from numerous species
we sought to examine the possible ferritin like functions of RGI1 in
yeast [2,13,17,25,26]. As a ﬁrst step, we sought to determine if the
overexpression of RGI1 can prevent the effects of Bax in yeast like
we observe with FTH1. Using spot assays with cells overexpressing
RGI1 it is readily apparent that it can prevent the effects of Bax as
RGI1 increases the growth of cells that are co-expressing Bax
compared to cells that express Bax alone (Fig. 1C). Thus RGI1, like
FTH1, is a Bax suppressor that can prevent the well known dele-
terious effect of Bax but it is unlikely that they speciﬁcally inhibit
Bax itself [16].
2.2. Ferritin and RGI1 prevent copper stress mediated cell death in
yeast
One of the characteristics of many if not all ferritins, is their
ability to decrease stress mediated cell death when overexpressed
[4,27]. To determine whether human ferritin and yeast RGI1 are
general inhibitors of PCD in yeast rather than solely being Bax
suppressors, we used another cell stress to test their abilities to
prevent cell death. Copper is a well-known apoptotic inducer that
can be prevented by overexpression of anti-apoptotic sequences
[28–31]. Using the spot assay, cells containing empty vector, a
vector expressing FTH1 or yeast RGI1 grew equally well on nu-
trient agar media containing glucose (Fig. 2A). When challenged
with increasing concentrations of copper, the growth of the con-
trol cells was noticeably inhibited in a dose dependant manner. In
contrast the growth of the cells harbouring the yeast RGI1 or the
FTH1 expressing constructs were noticeably less affected by the
presence of copper in the media (Fig. 2A). Human 14-3-3β/α, a
previously characterized Bax suppressor, also blocked the effects
of copper and served as a positive control (Fig. 2A) [19].
When grown on galactose alone with no copper, the induction
of RGI1 and ferritin appears to cause a growth inhibition that is
more pronounced that what is observed with 14-3-3 alone
(Fig. 2A). These results are consistent with reports showing that
overexpressed ferritin decreases cell growth [32,33]. Increasing
iron concentration in the growth media partially reverses this ef-
fect [32]. Thus a ferritin mediated decrease in the labile iron pools
(LIP) appears to be responsible for the effects of overexpressed
ferritin on growth. A direct measurement of doubling times
showed that cells expressing FTH1 or RGI1 have signiﬁcantly de-
creased growth rates. The doubling time of control cells is
202 min711, while cells overexpressing FTH1 or RGI1 had in-
creased doubling time of 277 min710 and 288 min73 respec-
tively (po0.005 for control vs. ferritin cells, using a student t-test).
Microscopic examination of stained cells with the vital dye trypan
blue revealed that the viability of the FTH1 or RGI1 transformants
remained above 98% even after 16 h of growth in galactose media
(see Fig. 2B). Thus FTH1 or RGI1 expression in yeast results in a
decrease in the growth of cells. The observed effects on growth
could not be readily reversed by the addition of a 10-fold excess
iron in the growth media (not shown). Although iron depletion
may be the mechanism for slow growth, it remains that theobserved effects may be related to the non-speciﬁc effects that
high level of expression can sometimes induce [34].
Because the spot assay only measures growth, we again used
trypan blue to assess the ability of ferritin and RGI1 to prevent cell
death. The viability of cells in liquid culture was determined after
18 h of incubation with or without 1.4 mM copper. For all strains,
the viabilities remained above 98% after 18 h of growth in the
absence of copper (Fig. 2B). In contrast the viability of control cells
was signiﬁcantly decreased to 29.271.9% by copper. At the same
time, cells overexpressing 14-3-3β/α, FTH1 or RGI1 had respective
viabilities of 79.376.9%, 70.873.3% and 75.371.9% when grown
with copper (signiﬁcant differences with student t-test, p40.001)
(Fig. 2B). Similar results were obtained using the clonogenicity
assay. As we previously observed the viability of copper-treated
control cells was signiﬁcantly reduced to 6.471.9% [31]. The via-
bility of copper-treated cells expressing FTH1 or RGI1 was in-
creased to a respective 21.873.7% and 24.274.4%. Therefore FTH1
and RGI1 are pro-survival proteins that can protect cells from
stress induced cell death.
There are a large number of pathways that induce PCD and this
can occur by a variety of different processes including the activa-
tion of pro-apoptotic proteins [35,36]. One key gene that is com-
monly activated is the YCA1-encoded metacaspase and cells lack-
ing this gene have an altered response to a number of stresses [37].
It remains that pro-survival proteins may function by directly in-
hibiting speciﬁc pro-PCD proteins including caspases or by in-
hibiting stress induced pathways that activate PCD [8]. Here we
use the growth spot assay to show that FTH1 and RGI1 retain the
ability to prevent the effects of copper when expressed in the
MCA1 deletion mutant (Fig. 2C). Cells were spotted onto nutrient
agar with 1.6 mM copper instead of 1.8 or 2.0 mM since these cells
are more sensitive than wild type cells to copper [24,30].
An increase in Reactive Oxygen Species (ROS) is a commonly
observed response to stress. In effect, increased levels of ROS are a
commonly monitored hallmark of PCD [38]. Here we used the cell
permeable DCFH-DA that is oxidized to a ﬂuorescent chromophore
(2′7′-dichloroﬂuorescein) by ROS generating molecules (i.e. hy-
drogen peroxide) as a tool to detect increases in ROS. Untreated
control and RGI1 expressing cells show minimal ﬂuorescence with
DCHF-DA treatment indicating low basal levels of endogenous ROS
(Fig. 2D). In contrast, control cells treated with copper stress have
a high proportion of the cells (71.376.8%) that show ﬂuorescence
(Fig. 2D). The percentage of ﬂuorescent cells was reduced to
18.374.6% in cells expressing RGI1 (Fig. 2D). This suggests that
RGI1 prevents the accumulation of stress induced ROS. Taken to-
gether these results indicate that FTH1 and RGI1 are pro-survival
sequences that can prevent the effects of apoptotic inducing
stresses. The results obtained with RGI1 are consistent with the
observation that the RGI1 encoding gene is regulated by many
different stimuli including a number of stresses that can lead to
PCD [17].
2.3. RGI1p does not form protein nanocages
Human ferritin self-assembles into a protein nanocage cage of
24 ferritin subunits that enclose a large cavity where iron is de-
posited as a ‘core’ of ferrihydrite [4]. In order to further test the
possible functional equivalence of yeast RGI1p to FTH1, we also
compared the structural characteristics of our recombinant RGI1p
to those of recombinant ferritin. Our recombinant FTH1 behaved
as expected, as bands of approximately 20 kDa, compatible with
hFerritin monomers, were observable upon denaturing SDS-PAGE
(Fig. 3A, full arrow) [27]. On the other hand, recombinant FTH1
presented as single high molecular weight (4250 kDa) bands
upon semi-denaturing SDS-PAGE (Fig. 3A, full arrowheads). In-
terestingly, the inclusion of FeCl2 (þ) served to preserve this high
Fig. 3. In vitro analysis of human ferritin and and yeast Rgi1p proteins. Recombinant human H-ferritin and Rgi1pwere incubated with (þ) or without () 0.5 mM FeCl2. After
incubation, the resulting samples were run in denaturing and semi-denaturing SDS-PAGE conditions. Photographs of the gels stained with coomassie are shown. Full arrow
point to bands compatibles with hFerritin monomers, while full arrowheads point to high molecular weight bands compatible with hFerritin protein nanocages. hFerritin
nanocages were directly observed by negative stain EM (small, full arrows). Open arrow points to a band compatible with Rgi1p monomer, while small and big open
arrowheads points to bands compatible with RGI1 dimers and tetramers, respectively.
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rowhead). As the puriﬁcation condition of our protein extracts
were designed to minimize lost of native conformation, we in-
terpreted this high molecular weight band to be ferritin nanocages
[4,12,39]. Indeed, negative stain EM of our recombinant FTH1
preparations revealed the presence of structures (Fig. 3A, right
side, full arrowheads) compatible to previously described ferritin
nanocages [40]. On the other hand, recombinant RGI1p and RGI2p
(data not shown) constantly produced a band pattern that was
highly resistant to denaturation. Indeed, 19 kDa bands compatible
with RGI1p (Fig. 3A, lower panels, open arrow) and RGI2p (data not
shown) monomers were only observable in denaturing conditions
and were largely independent of pre-incubation with FeCl2 (þ).
Similarly, bands compatible with RGI1p dimers were observable
irrelative of FeCl2 incubation, or denaturing condition (Fig. 3A,
open arrowhead). It is also worth noting that a weak band of about
76 kDa, compatible with an RGI1p tetramer, could also be observed
in our semi-denaturing conditions (Fig. 3A, large open arrowhead).
Conversely, the formation of high molecular weight complexes
compatible with the formation of nanocages was never observed
for RGI1p or RGI2p (data not shown). Similarly, negative stain EM
of recombinant RGI1p (Fig. 3A, left lower panel) or RGI2p (data not
shown), did not reveal the presence of hFerritin-like nanocagesstructures. It should be noted that we included RGI2p since it
shares 67% sequence identity with Rgi1p [17].
2.4. Iron, programmed cell death, RGI1 and ferritin
Excess iron leads to cell damage and cell death at least in part
by inducing apoptosis-like programmed cell death [10,41]. Iron has
a limited solubility and a chelating system such as citrate is re-
quired to achieve high concentrations in cell growth media [42].
Other modiﬁcations to study iron toxicity in standard mammalian
cell culture systems or in yeast have included using sublethal iron
in combination with other sublethal stresses such as neuro-
hormones, chemicals and the use of serum free growth media
[27,43,44]. Other approaches include the use of a variety of dif-
ferent genetically altered cells, including mammalian and yeast,
that are supersensitive to iron [11,20,42,45]. For yeast, mutants
defective in genes encoding vacuolar iron/copper transporter or
the vacuolar proton pump are commonly used [11,45]. Using a
spot assay, we show that proton pump defective Vma3Δ is more
sensitive to iron as compared to wild type cells (Fig. 4A). In effect,
yeast Vma3Δ cells harbouring empty vector grow well on normal
media but they decrease in their ability to grow as the media is
supplemented with added iron as low as 1 mM and are unable to
Fig. 4. Functional analysis of RGI1 in response to iron stress in yeast. (A) The spot assay was used to assess the ability of wild type (WT) and VMA3Δ mutant (VMA3Δ)
expressing FTH1 (hferritin) or RGI1 for their ability to grow when challenged with 1 or 3 mM iron (FeCl3). (B) The spot assay was used to assess the ability of wild type cells
expressing yeast RGI1 for their ability to grow with 8 mM iron. (C) Yeast mutants lacking RGI1 are speciﬁcally hypersensitive to iron. The spot assay using YEPD agar plates
without (Control) or with the indicated concentrations of iron, copper or zinc were used to assess the growth of wild type and RGI1Δ and RGI2Δ mutants. (D) The effect of
increasing and decreasing RGI1 expression levels on intracellular iron in yeast. Wild type cells with empty vector (Vector) or the RGI1 expressing plasmid (RGI1) as well as
mutant RGI1Δ or RGI2Δ were grown for 18 h in absence (–) or presence of a 10 fold excess of iron (Fe) (þ). The cells were harvested and total iron was determined using a
colorimetric assay. The data are presented relative to the iron content found in control yeast cells growing in normal YNB galactose media (1¼5.270.4 ng iron/108 cells). The
data are shown as the mean of triplicate experiments that were repeated at least 3 times. *, indicates that the values obtained in the presence of 10-fold excess iron are
signiﬁcantly different than the values obtained when grown in unsupplemented media (student t test, po0.05).
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cells with empty vector alone are unaffected by the added iron.
The yeast Vma3Δ cells expressing either FTH1 or RGI1 are able to
grow with 1 mM added iron (Fig. 4A). Therefore, our results in-
dicate that RGI1, like the previously characterised FTH1, can re-
verse the supersensitivity to iron mediated growth inhibition of a
cell with a defective vacuole [20].
Ferritins are reported to protect against the effects of excess
iron by serving to store iron as well as by directly protecting from
the toxic effect of excess iron [4,12]. These reported hallmark
characteristics are observed with many ferritins and in many cell
types overexpressing ferritin including cultured mammalian cells
and the yeast S. cerevisiae [6,18,20,27,46,47]. It thus remains that
for RGI1 to be considered a ferritin it must be able to protect wild
type cells from iron. To bypass the limitations of iron solubility we
used nutrient agar plates to assess the effect of iron on the growth
of yeast. Even though the iron is likely precipitated in the agar it
appears to remain bioavailable as it often used to effectively in-
hibit wild yeast growth [11]. To assess the possibility that RGI1
may have these ferritin-like functions, yeast cells harbouring the
empty vector or the RGI1 expressing vector were grown on nu-
trient agar plates with iron. The growth of wild type cells trans-
formed with empty vector is noticeably inhibited with 8 mM iron
(Fig. 4B). This sensitivity to growth on media containing 8 mM iron
was not noticeably altered in cells overexpressing RGI1 (Fig. 4B).This indicates that RGI1 does not confer an increased resistance to
iron. Taken together the results indicate that RGI1 is not protective
of excess iron under standard conditions. Given that RGI1 prevents
the effects of iron in Vma3Δ cells, our results indicate that the iron
toxicity induces different effects in wild type and Vma3Δ cells.
Gene knock out experiments have suggested that the loss of
gene function for many proteins involved in iron metabolism such
as ferritin or the vacuolar iron transporter can lead to iron accu-
mulation and disruption of iron mediated responses [48]. If RGI1p
is involved in iron metabolism, we hypothesized that the loss of
the RGI1 gene should lead to an iron speciﬁc phenotype. As a
simple way of testing this, we used the spot assay to determine the
effect of iron on the growth of wild type, RGI1Δ and RGI2Δ yeast
cells. All three strains show similar growth when spotted on rich
YEPD nutrient growth media (Fig. 4C). In contrast, when the same
strains were spotted on media containing increasing iron con-
centrations, there were noticeable decreases in the ability of RGI1Δ
and RGI2Δ mutants to grow compared to their isogenic wild type
counterpart (Fig. 4C). In contrast, the same three yeast strains
show similar sensitivity to the inhibitory effects of copper and zinc
(Fig. 4C). Thus the loss of RGI1 leads to a speciﬁc iron super-
sensitive phenotype that is reminiscent of a number of other iron-
speciﬁc yeast genes such as CCC1 [11]. These results indicate that
RGI1 is involved in iron metabolism. In contrast, the previous re-
sults showing no effect of RGI1 overexpression on iron sensitivity
R. Eid et al. / Experimental Cell Research 342 (2016) 52–6158in wild type cells (Fig. 4B) indicates that its basal level of expres-
sion is not rate limiting for iron metabolism.
Ferritin has been reported to bind iron as a protein dimer as
well as to store large number of iron atoms in their nanocages
[12,27,47]. To examine if there is an increased iron storage capacity
in cells overexpressing RGI1, we grew the yeast transformants in
normal media and in media with a 10-fold excess of iron. After
18 h, the cells that were still in exponential growth (OD600 be-
tween 0.3 and 0.8) were harvested and their iron content de-
termined using a colorimetric assay [49]. When grown with a 10-
fold increase in iron, the iron content of both control cells and of
RGI1 overexpressing cells was increased 2-fold (Fig. 4D). The
magnitude of the increased iron content for control cells is con-
sistent with published reports suggesting that cells likely avoid
iron toxicity by limiting the uptake of excess iron [9,15,50]. The
similarity in the magnitude of increase in iron content without and
with overexpressed RGI1 indicates that the protein is incapable of
storing large amounts of iron that is present in excess in the
growth media. Changing growth conditions may lead to altera-
tions in the storage of iron in ferritin. For example, the iron con-
tent of Escherichia coli cells is increased 2-fold by ferritin in sta-
tionary phase compared to logarithmically growing cells [51].
Therefore, we examined the iron content of cells growing with
excess iron when they reached stationary phase. The iron content
of stationary phase cells were virtually indistinguishable from the
results obtained with growing cells as shown in Fig. 4D. In effect,
cells expressing ferritins also showed a similar 2-fold increase in
the levels of iron when they were grown for 18 h with a 10-fold
excess iron (not shown). This indicates that there was no sig-
niﬁcantly augmented iron storage occurring due to the presence of
increased RGI1. Finally we also examined the iron storage capacity
of cells lacking RGI1 or RGI2. As with wild type cells, cells lacking
RGI1 or RGI2 show a 2-fold increase in their iron content when
grownwith a 10-fold increase in iron in their media (Fig. 4D). Thus
endogenously expressed RGIs do not appear to play a role in
modulating the storage of iron in yeast cells.3. Discussion
Here we show that human H-ferritin as well as yeast Rgi1p are
novel pro-survival sequences that are capable of preventing the
deleterious effects of heterologously expressed Bax as well as the
PCD response to excess copper (Figs. 1, 2 and 5). In spite of theseFig. 5. A model depicting the relationship between Rgi1p and PCD in yeast. Exo-
genous copper (Cu) and iron (Fe) as well as the heterologously expressed Bax are
shown as inducers of Programmed Cell Death (PCD). Copper induces the formation
of reactive oxygen species (ROS). Human ferritin and Rgi1p can block the copper
and Bax mediated PCD while ferritin is reported to prevent PCD from multiple
stresses including iron [20,27].similarities and in spite of sharing 20% sequence similarity with
FTH1, Rgi1p does not have the hallmark characteristics of a ferritin
(Fig. 1). Thus recombinant Rgi1p, unlike what we observed with
recombinant ferritin, is unable to form large molecular structures
and is unable to protect from iron toxicity or increase iron content
when overexpressed in yeast (Fig. 3). Nevertheless the increased
sensitivity of yeast mutants lacking RGI1 to iron, but not to copper
or zinc, indicates that Rgi1p may have a role to play in mediating
the response to excess iron (Fig. 4). These observations regarding
the pro-survival function of Rgi1p are consistent with previous
reports showing that RGI1 expression is regulated by multiple
stresses including iron [17]. These studies are of interest because
the function of RGI1 remains unknown [17]. Orthologues of RGI1
are present in a very limited subset of yeast species which suggests
that it may fulﬁl a rather speciﬁc function [17]. As such, RGI1 may
be similar to a number of other such proteins like UTH1 which was
also identiﬁed as a modulator of murine Bax mediated cell death
in yeast [52].
The question remains as to how RGI1 may function to inhibit
PCD. In spite of a great deal of advances in our understanding of
PCD there is still a lack of understanding of most pro-survival
processes [8,53–55]. Many anti-apoptotic studies have focused on
identifying and characterizing sequences that serve to prevent or
delay PCD. These studies have basically identiﬁed four types of
pro-survival proteins. One (1) functions by reducing the levels of
pro-death 2nd messengers such as Reactive Oxygen Species (ROS)
and iron [56,57]. A second (2) directly interferes with a pro-
apoptotic protein (i.e., the Bcl-2 protein prevents PCD by binding
the pro-apoptotic Bax) [8,58]. A third (3) consists of chaperones
including many heat shock proteins (hsp) that bind damaged
proteins and reduce intracellular stresses [59]. A fourth (4) con-
tains a large number of proteins that are pro-survival by as of yet
unknown mechanism [60]. Within the latter group, some of these
may function to induce the activation of pro-survival processes
such as autophagy [61]. Identiﬁcation and functional character-
ization of pro-survival proteins like RGI1p is required to get a
complete understanding of the mechanisms involved in regulating
PCD.
It is of interest that the pro-survival functions of RGI1 and
ferritin are retained in mutants lacking MCA1 (Fig. 2C). The MCA1
encoded metacaspase has been shown to be involved in mediated
the effects of many but not all stresses that induce PCD in yeast
[62]. This indicates that as in mammalian systems, yeast harbours
several distinct PCD activating pathways [63,64]. The ability to use
mutants defective in different pro-apoptotic proteins is proving to
be a useful strategy to map the different cell death processes in
yeast [36]. For example, the characterization of ferritin function in
yeast has been facilitated by cells that are defective in vacuolar
function that have reduced necrosis and increased sensitivity to
iron [20].4. Material and methods
4.1. Yeast strains and plasmids
The wild type S. cerevisiae strain BY4742 (MATα his3Δ1 leu2Δ0
lys15Δ0 ura3Δ0) and the isogenic RGI1Δ, RGI2Δ, VMA3Δ and
MCA1Δ were used. Plasmids containing the cDNAs for FTH1 and
14-3-3β/α were isolated from our previous Bax screen [16]. Plas-
mid for expressing RGI1 (YER067W) on a URA3 selectable marker
vector was obtained from Thermo Scientiﬁc. Murine Bax was ex-
pressed on a plasmid with a HIS3 selectable marker previously
described [16]. All clones are expressed under the control of the
galactose inducible GAL1 promoter.
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Yeast cells transformed with the various plasmids were se-
lected for and maintained by excluding the appropriate nutrients
from the media. In some instances, yeast was grown in rich media
containing 2% Bacto peptone, 1% yeast extract, and 2% glucose
(YEPD). However, yeast cells were routinely grown in synthetic
minimal media consisting of yeast nitrogen base (YNB), 2% glu-
cose, and the required amino acids or bases. In order to induce
gene expression of sequences under the GAL1 promoter control,
glucose was replaced with 2% galactose and 1% rafﬁnose. Spot
assays, using serially diluted cells from freshly saturated cultures,
were used to assess the ability of different transformants to grow
in varying conditions [30,34]. Viability was determined by mi-
croscopic examination of cells stained with the vital dye trypan
blue that had grown for 18 h in YNB galactose media with 1.4 mM
of copper sulphate (CuSO4) [30,34]. At least three different sam-
ples of 300 cells were scored for each culture and the experiment
was repeated at least three different times obtaining similar re-
sults. Viability was also determined using the clonogenicity assay
as previously described [31,65]. Brieﬂy, cells grown for 18 h
without and with 1.4 mM copper sulphate were plated on YEPD
media and the numbers of colonies grown after 48 h were de-
termined. Viability is reported as the ratio of colonies formed by
copper treated and untreated cells. The data from the viability
experiments are presented as the mean7standard deviation of
triplicate experiments repeated a minimum of three independent
times. Statistical signiﬁcance of the data was determined using a
student t test. All described experiments were carried out a
minimum of three independent times.
To detect intracellular ROS, galactose growing cells were treated
with 1.4 mM copper, incubated for 4 h at 30 °C and dichloro-dihydro-
ﬂuorescein diacetate (DCFH-DA) was added to a ﬁnal concentration of
20 μg/ml. The cultures were further incubated for an additional 2 h
and the cells were washed twice with water. Live cells were visualized
using ﬂuorescent microscopy through a FITC optical ﬁlter and the
images were photographed and analyzed as described [65,66].
For iron assays, cells were inoculated at low or moderate cell
densities in fresh galactose media (5 ml or 50 ml in 10 ml). The
cultures were grown for 18 h with or without the addition of 10
more iron than standard YNB media. Cells were harvested and
washed 3 times with cold 1 mM EDTA, ﬂash frozen and stored at
70 °C. The cells were broken with 3% nitric acid (98 °C, 18 h) and
iron content was determined using a colorimetric assay using the
iron chelator ferrozine [49]. All described experiments were car-
ried out a minimum of three independent times.
4.3. Production and analysis of recombinant human H-ferritin and
yeast RGI proteins
S. cerevisiae RGI1 (NM_001178958), RGI2 (NM_001179407), and
human H-ferritin (BC104643) coding sequences were ampliﬁed by
PCR from yeast genomic DNA and human cDNA respectively using
the following conditions: an initial denaturation for 10 min and
then 25 cycles of 15 s at 95 °C, 30 s at 58 °C (RGI1 and RGI2) or
64 °C (hFerritin) and 45 s at 72 °C. The speciﬁc sense/antisense
primer sets were: RGI1: GGGGGATCCATGACAAAGAAGGATAAGAA/
GGGGCGGCCGCGTTAATTTGCGCCTACAGGATG; RGI2: GGGGGATC-
CATGACGAAAAAGGATAAGAAA/ GGGGCGGCCGCGTTAGATGAGTG-
GCTGCAAGGG; hFerritin: GGGGGATCCATGACGACCGCGTCCACCTC-
G/GGGGCGGCCGCGTTAGCTTTCATTATCGTC. Underlined sections of
the sequences indicate the introduced BamH1 (sense) and Not1
(antisense) restriction endonuclease sites that were used to clone
the fragments into the pSMT3 expression vector. pSMT3 permits
the expression of recombinant proteins containing a dual His-Tag/
Sumo label. The resultant recombinant protein can therefore bepuriﬁed via its His-Tag, which is linked to the protein by SUMO
sites that may later be cleaved by Ubl-speciﬁc protease 1 (ULP1)
[67].
The RGI1-, RGI2- and hFerritin-pSMT3 expression vectors were
transformed into BL21(DE3) E. coli strain. The transformants were
then cultured in LB until log-phase, at which point expression was
induced by the addition of IPTG (1 mM), followed by overnight
culture at 20 °C. The cells were lysed by homogenization in ice
cold buffer consisting of 10 mM Tris pH 7.5, 250 mM KCl, 25 mM
imidazole, 1 mM BME, 1 mM PMSF and 10% glycerol. The re-
combinant proteins were puriﬁed from total extracts with col-
umns of Ni-NTA agarose beads (McLAB). The bound proteins were
washed with several volumes of lysis buffer, then with wash buffer
(10 mM Tris pH 7.5, 500 mM KCl, 25 mM imidazole, 1 mM BME,
1 mM PMSF and 10% glycerol). The His-Tag protein fractions were
then eluted from the column with a buffer consisting of 10 mM
Tris pH 7.5, 250 mM KCl, 500 mM imidazole, 1 mM BME, 1 mM
PMSF and 10% glycerol. Afterwards, eluted fractions were dialysed
overnight at 4 °C in a buffer consisting of 10 mM Tris pH 7.5,
250 mM KCl, 1 mM BME, and 10% glycerol. The His-Tag and sumo
linker were cleaved by addition of ULP protein to the eluted lysates
during dialysis, and subsequently removed on Ni-NTA agarose
bead gravity columns. The resulting protein extracts contained
highly puriﬁed recombinant Rgi1p, Rgi2p and hFerritin proteins as
evidenced by SDS-Page analysis (Fig. 3).
The structural characteristics of Rgi1p and Rgi2p were compared
to that of hFerritin via SDS-PAGE assays. Brieﬂy, equal volumes of
protein extracts (25 μMol) were mixed and incubated at 20 °C for
1 h without and with FeCl2 (0.5 mM). The resulting samples were
split in two, and run on 12.5% SDS-PAGE under denaturing (2.5%
BME, 5 min boil) and semi-denaturing (no added BME, no boil)
conditions. Running buffer consisted of 0.1% SDS, 25 mM Tris and
192 mM glycine. Molecular weight maker consisted of broad-range
dual colour marker (Bio-Rad). The gels were stained with coomassie
blue and photographs of the gels are shown.
4.4. Negative stain electron microscopy (EM)
Samples of recombinant proteins were ﬁrst diluted to 1 mg/mL
in a dilution buffer consisting of 10 mM Tris and 250 mM KCl. Ne-
gative stain EM samples were prepared by applying the diluted
Rgi1p, Rgi2p and hFerritin proteins solutions to carbon-coated, glow
discharged copper grids. Protein-coated grids were then stained
with 2% uranyl acetate (Electron Microscopy Sciences Co.). Negative
stain EM was performed on a Tecnai T12 spirit microscope (FEI Co.)
operating at 120 kV, and images were acquired on a CCD camera
(https://www.mcgill.ca/femr/facilities). Micrographs were then ta-
ken at 49,000 and 120,000 magniﬁcation. Scale bars¼20 nm.Acknowledgements
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